10 |
10
하기로부터 선택된 것을 특징으로 하는 제 1 항의 레조사이클릭산 락톤계 화합물 합성용 중간체 화합물 : 5-(3-(하이드록시메틸)페닐)-7-메톡시-2,2-디메틸-4H-벤조[d][1,3]디옥신-4-온);3-(7-메톡시-2,2-디메틸-4-옥소-4H-벤조[d][1,3]디옥신-5-일)벤즈알데히드;(E)-메틸 3-(3-(7-메톡시-2,2-디메틸-4-옥소-4H-벤조[d][1,3]디옥신-5-일)페닐)아크릴레이트;(2S,3R)-메틸 2,3-디하이드록시-3-(3-(7-메톡시-2,2-디메틸-4-옥소-4H-벤조[d][1,3]디옥신-5-일)페닐)프로파노에이트;(4S,5R)-메틸 5-(3-(7-메톡시-2,2-디메틸-4-옥소-4H-벤조[d][1,3]디옥신-5-일)페닐)-2,2-디메틸-1,3-디옥소란-4-카복실레이트;(4S,5R)-메틸 5-(3'-하이드록시-5'-메톡시-2'-(메톡시카보닐)-[1,1'-바이페닐]-3-일)-2,2-디메틸-1,3-디옥소란-4-카복실레이트;(4S,5R)-메틸 5-(5'-메톡시-2'-(메톡시카보닐)-3'-(메톡시메톡시)-[1,1'-바이페닐]-3-일)-2,2-디메틸-1,3-디옥소란-4-카복실레이트;메틸 3'-((4R,5R)-5-(하이드록시메틸)-2,2-디메틸-1,3-디옥소란-4-일)-5-메톡시-3-(메톡시메톡시)-[1,1'-바이페닐]-2-카복실레이트;메틸 3'-(4R,5R)-5-((5R)-5-(tert-부틸디페닐실릴)옥시)-1-하이드록시헥스-2-인-1-일)-2,2-디메틸-1,3-디옥소란-4-일)-5-메톡시-3-(메톡시메톡시)-[1,1'-바이 페닐]-2-카복실레이트;메틸 3'-(4R,5R)-5-((5R)-5-((tert-부틸디메틸실릴)옥시)-1-하이드록시헥스-2-인-1-일)-2,2-디메틸-1,3-디옥소란-4-일)-5-메톡시-3-(메톡시메톡시)-[1,1'-바이페닐]-2-카복실레이트;메틸 3'-((4R,5R)-5-((5R,Z)-5-((tert-부틸디페닐실릴)옥시)-1-하이드록시헥스-2-엔-1-일)-2,2-디메틸-1,3-디옥소란-4-일)-5-메톡시-3-(메톡시메톡시)-[1,1'-바이페닐]-2-카복실레이트;메틸 3'-((4R,5R)-5-((5R,Z)-5-((tert-부틸디메틸실릴)옥시)-1-하이드록시헥스-2-엔-1-일)-2,2-디메틸-1,3-디옥소란-4-일)-5-메톡시-3-(메톡시메톡시)-[1,1'-바이페닐]-2-카복실레이트;메틸 3'-((4R,5R)-5-((5R,Z)-5-((tert-부틸디페닐실릴)옥시)-1-((4-메톡시벤질)옥시)헥스-2-엔-1-일)-2,2-디메틸-1,4-디옥소란-4-일)-5-메톡시-3-(메톡시메톡시)-[1,1'-바이페닐]-2-카복실레이트;메틸 3'-((4R,5R)-5-((5R,Z)-5-((tert-부틸디메틸실릴)옥시)-1-((4-메톡시 벤질)옥시)헥스-2-엔-2-일)-2,2-디메틸-1,3-디옥소란-4-일)-5-메톡시-3-(메톡시메톡시)-[1,1'-바이페닐]-2-카복실레이트;메틸 3'-((4R,5R)-5-((5R,Z)-5-하이드록시-1-((4-메톡시벤질)옥시)헥스-2-엔-1-일)-2,2-디메틸-1,3-디옥소란-4-일)-5-메톡시-3-(메톡시메톡시)-[1,1'-바이페닐]-2-카복실레이트;(3aR,8S,19aR,Z)-13-메톡시-4-((4-메톡시벤질)옥시)-11-(메톡시메톡시)-2,2,8-트리메틸-7,8,19,19a-테트라하이드로-3aH-디벤조[c,e][1,3]디옥솔로[4,5-h][1]옥사사이클로테트라데킨-10(4H)-온;(3aR,8S,19aR,Z)-4-하이드록시-13-메톡시-11-(메톡시메톡시)-2,2,8-트리메틸-7,8,19,19a-테트라하이드로-3aH-디벤조[c,e][1,3]디옥솔로[4,5-h][1]옥사사이클로테트라데신-10(4H)-온; 또는(3aS,8S,19aR,Z)-13-메톡시-11-(메톡시메톡시)-2,2,8-트리메틸-7,8,19,19a-테트라하이드로-3aH-디벤조[c,e][1
|